Assisted Reproductive Techniques (ART) and their possible effect on the progression of endometriosis symptoms

preprint OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This prospective cohort study found no worsening of endometriosis symptoms or quality of life in women undergoing assisted reproductive techniques compared to control groups.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

The provided text does not describe a biomedical study or include methods, participant populations, measured outcomes, results, or limitations; it appears to be an event listing or conference promotional material rather than a paper with scientific findings. As a result, no key finding or explicit caveat can be extracted from the content given. The paper’s only apparent content is its title, which indicates an investigation into how assisted reproductive techniques might affect the progression of endometriosis symptoms. Relevance to endometriosis: the corpus inclusion is based on the paper title mentioning ART and endometriosis symptom progression, though the full text supplied contains no study details or results.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Study question: Do women with endometriosis experience worsening in endometriosis symptoms (quality of life, pain, bowel symptoms) when undergoing controlled ovarian stimulation (COS) during assisted reproductive techniques (ART)? Summary answer: This study did not find worsening in the abovementioned parameters during ART, which supports ART as a suitable therapeutic option for infertile women with endometriosis. What is known already: 10-25% of women with endometriosis require ART to conceive. During COS levels of estrogen increases, hence in theory increasing the risk of progression of symptoms related to endometriosis. Anaf et al. identified four cases of rapidly growing sigmoid endometriosis during ovarian stimulation resulting in cessation of ART and bowel surgery. Ten similar cases have occurred in our department since 2007. Moreover, isolated cases with severe worsening of endometriosis during COS have been reported. Study design, size, duration: Prospective cohort study carried out from February 2016 to October 2017 with a total of 177 women recruited. Participants were excluded during the study if they were lost to follow-up, or if egg retrieval was cancelled. This study is based on questionnaires containing the Endometriosis Health Profile (EHP-30), and pain and bowel habits were evaluated on the numerical rating scale (NRS). Questionnaires were administered before and after COS in one cycle of ART. Participants/materials, setting, methods: Patients < 40 years old were recruited from three fertility clinics and the endometriosis unit, Aarhus University Hospital (AUH). Depending on endometriosis diagnosis (confirmed by previous laparoscopy, transvaginal ultrasound or magnetic resonance imaging) and ART, patients were assigned one of three groups (endometriosis with or without ART, or no endometriosis undergoing ART). According to power calculations each group should include 48 women. Median and mean changes in pain and quality of life scores are reported. Main results and the role of chance: 52 women with endometriosis undergoing ART (+Endo/+ART), 50 not undergoing ART (+Endo/-ART), and 52 without endometriosis undergoing ART (-Endo/+ART), answered two questionnaires. The three groups differed significantly on all pain parameters (general and worst non-menstrual pelvic pain, dyschezia, dyspareunia, and dysuria) at baseline, women without endometriosis had a significantly better score in all EHP-30® modules (pain, control and powerlessness, social support and emotional well-being) except self-image where the groups did not differ. Bowel parameters (constipation, diarrhea, nausea, vomiting and bloating) were comparable between the groups, except that +Endo/-ART indicated worse bloating. Changes from 1st to 2nd questionnaire indicated that -Endo/+ART experienced a one NRS point greater worsening in the parameters 'tired” and 'general non-menstrual pelvic pain” compared to women with endometriosis (p=0.003, and p<0.001). Regarding worst non-menstrual pelvic pain, the median changes were 1, 2.5, and 0 for +Endo/+ART, -Endo/+ART, and +Endo/-ART, respectively (p<0.001). Women with endometriosis, undergoing ART or not, experienced a slight improvement in EHP-30® modules during ART compared to -Endo/+ART who worsened in all modules except 'self-image”. None of the three groups changed in bowel parameters except bloating where both ART groups experienced an increase of one NRS point compared to +Endo/-ART (p=0.020). Limitations, reasons for caution: Women with endometriosis were included regardless of stage, which caused disease heterogeneity. +Endo/-ART was recruited from a tertiary referral center. Hence, this group may have particularly severe endometriosis stages. In the group of women without endometriosis subclinical disease might have been present without the clinicians’ knowledge. Wider implications of the findings: Our results are in line with previous studies (Benaglia et al. and Coccia et al.) which further supports ART as a suitable therapeutic option for infertile women with endometriosis. Our two reference groups added new information by allowing differentiation between changes in parameters caused by ART and endometriosis individually. Trial registration number: The Danish Data Protection Agency: Registration number 2012-58-006). ClinicalTrials.gov: NCT02762461. Keywords: Endometriosis Artificial reproductive techniques (ART) quality of life Bowel symptoms
Full text 523 characters · extracted from oa-doi-fallback · click to expand
Conference New York, United States · - morressier.com Giving chemistry professionals a platform to present, publish, discuss and exhibit the most exciting research discoveries and technologies in chemistry and its related disciplines. The meeting will facilitate networking opportunities, career development and placement, and provide companies an opportunity to exhibit products and services to a targeted audience. Hosted By International Chemistry & Technology Society Discover more research and events on morressier.com

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Outcome instruments

EHP-30 NRS-pain

Condition tags

endometriosisdyspareunia

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK